Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates

J Marchart1, G Dropmann, S Lechleitner

  • 1Institute of Microbiology and Genetics, University of Vienna, Vienna, Austria.

Vaccine
|August 19, 2003
PubMed

Insights

Bacterial ghosts, empty bacterial cells, effectively lysed Pasteurella multocida and Pasteurella haemolytica. These Pasteurella ghosts show potential as novel vaccine candidates, inducing protective immunity in animal models.

Area of Science:

  • Veterinary Microbiology
  • Bacteriology
  • Immunology

Background:

  • Pasteurella multocida and Pasteurella haemolytica are significant animal pathogens.
  • Bacterial ghosts are non-living bacterial cells produced via phage lysis gene expression, lacking cellular contents.

Purpose of the Study:

  • To investigate the efficacy of bacterial ghosts for lysis and potential vaccine development against Pasteurella species.
  • To evaluate the immunogenicity and protective capabilities of Pasteurella ghosts.

Main Methods:

  • Lysis of Pasteurella multocida and P. haemolytica using phage PhiX174 lysis gene E expression.
  • Production of Pasteurella bacterial ghosts.
  • Immunization of rabbits and mice with Pasteurella ghosts.
  • Antibody response analysis and challenge studies in immunized mice.

Main Results:

  • Successful lysis and elimination of viable Pasteurella multocida and P. haemolytica cells were achieved using gene E expression.
  • Immunization with Pasteurella ghosts elicited antibodies against homologous and heterologous Pasteurella strains.
  • Mice immunized with P. multocida ghosts demonstrated dose-dependent protection against homologous challenge, with 100% protection at specific doses.

Conclusions:

  • Pasteurella bacterial ghosts are effective for lysing target bacteria.
  • Pasteurella ghosts serve as promising vaccine candidates, inducing protective immunity against Pasteurella infections.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Cross-reactivity00:42

Cross-reactivity

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...